Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
0
Like
Facebook
Tweet
Print
Yushi Ueki, MD, PhD
Disclosure information not submitted.
Presentation(s):
A075 - Blood eosinophil count may predict severe immune-related adverse events due to nivolumab in recurrent or metastatic head and neck squamous cell carcinoma
Posters